676 related articles for article (PubMed ID: 16048734)
21. Trimipramine in primary insomnia: results of a polysomnographic double-blind controlled study.
Riemann D; Voderholzer U; Cohrs S; Rodenbeck A; Hajak G; Rüther E; Wiegand MH; Laakmann G; Baghai T; Fischer W; Hoffmann M; Hohagen F; Mayer G; Berger M
Pharmacopsychiatry; 2002 Sep; 35(5):165-74. PubMed ID: 12237787
[TBL] [Abstract][Full Text] [Related]
22. Subjective versus objective evaluation of hypnotic efficacy: experience with zolpidem.
Kryger MH; Steljes D; Pouliot Z; Neufeld H; Odynski T
Sleep; 1991 Oct; 14(5):399-407. PubMed ID: 1759092
[TBL] [Abstract][Full Text] [Related]
23. Polysomnographic study of intermittent zolpidem treatment in primary sleep maintenance insomnia.
Parrino L; Smerieri A; Giglia F; Milioli G; De Paolis F; Terzano MG
Clin Neuropharmacol; 2008; 31(1):40-50. PubMed ID: 18303490
[TBL] [Abstract][Full Text] [Related]
24. Effects on sleep stages and microarchitecture of caffeine and its combination with zolpidem or trazodone in healthy volunteers.
Paterson LM; Nutt DJ; Ivarsson M; Hutson PH; Wilson SJ
J Psychopharmacol; 2009 Jul; 23(5):487-94. PubMed ID: 19351801
[TBL] [Abstract][Full Text] [Related]
25. Zolpidem and rebound insomnia--a double-blind, controlled polysomnographic study in chronic insomniac patients.
Monti JM; Attali P; Monti D; Zipfel A; de la Giclais B; Morselli PL
Pharmacopsychiatry; 1994 Jul; 27(4):166-75. PubMed ID: 7972349
[TBL] [Abstract][Full Text] [Related]
26. Sublingual zolpidem is more effective than oral zolpidem in initiating early onset of sleep in the post-nap model of transient insomnia: a polysomnographic study.
Staner L; Eriksson M; Cornette F; Santoro F; Muscat N; Luthinger R; Roth T
Sleep Med; 2009 Jun; 10(6):616-20. PubMed ID: 18996742
[TBL] [Abstract][Full Text] [Related]
27. Double blind comparison of zolpidem 20 mg versus flunitrazepam 2 mg in insomniac in-patients.
Frattola L; Maggioni M; Cesana B; Priore P
Drugs Exp Clin Res; 1990; 16(7):371-6. PubMed ID: 2092963
[TBL] [Abstract][Full Text] [Related]
28. Insomnia in somatoform pain disorder: sleep laboratory studies on differences to controls and acute effects of trazodone, evaluated by the Somnolyzer 24 x 7 and the Siesta database.
Saletu B; Prause W; Anderer P; Mandl M; Aigner M; Mikova O; Saletu-Zyhlarz GM
Neuropsychobiology; 2005; 51(3):148-63. PubMed ID: 15838186
[TBL] [Abstract][Full Text] [Related]
29. Polygraphical sleep recordings in insomniac patients under zopiclone or nitrazepam.
Jovanovic UJ; Dreyfus JF
Int Pharmacopsychiatry; 1982; 17 Suppl 2():136-45. PubMed ID: 7188371
[TBL] [Abstract][Full Text] [Related]
30. The dose effects of zolpidem on the sleep of healthy normals.
Merlotti L; Roehrs T; Koshorek G; Zorick F; Lamphere J; Roth T
J Clin Psychopharmacol; 1989 Feb; 9(1):9-14. PubMed ID: 2651493
[TBL] [Abstract][Full Text] [Related]
31. Controlled clinical trial of zolpidem for the treatment of insomnia associated with attention-deficit/ hyperactivity disorder in children 6 to 17 years of age.
Blumer JL; Findling RL; Shih WJ; Soubrane C; Reed MD
Pediatrics; 2009 May; 123(5):e770-6. PubMed ID: 19403468
[TBL] [Abstract][Full Text] [Related]
32. Short-term sleep laboratory studies with cinolazepam in situational insomnia induced by traffic noise.
Saletu B; Kindshofer G; Anderer P; Grünberger J
Int J Clin Pharmacol Res; 1987; 7(5):407-18. PubMed ID: 2889679
[TBL] [Abstract][Full Text] [Related]
33. Tiagabine increases slow-wave sleep in a dose-dependent fashion without affecting traditional efficacy measures in adults with primary insomnia.
Walsh JK; Perlis M; Rosenthal M; Krystal A; Jiang J; Roth T
J Clin Sleep Med; 2006 Jan; 2(1):35-41. PubMed ID: 17557435
[TBL] [Abstract][Full Text] [Related]
34. Short-term treatment with gaboxadol improves sleep maintenance and enhances slow wave sleep in adult patients with primary insomnia.
Lundahl J; Staner L; Staner C; Loft H; Deacon S
Psychopharmacology (Berl); 2007 Nov; 195(1):139-46. PubMed ID: 17653697
[TBL] [Abstract][Full Text] [Related]
35. Effect of cognitive behavioural therapy for insomnia on sleep architecture and sleep EEG power spectra in psychophysiological insomnia.
Cervena K; Dauvilliers Y; Espa F; Touchon J; Matousek M; Billiard M; Besset A
J Sleep Res; 2004 Dec; 13(4):385-93. PubMed ID: 15560773
[TBL] [Abstract][Full Text] [Related]
36. Effects of bretazenil vs. zolpidem and placebo on experimentally induced sleep disturbance in healthy volunteers.
Gieschke R; Cluydts R; Dingemanse J; De Roeck J; De Cock W
Methods Find Exp Clin Pharmacol; 1994 Nov; 16(9):667-75. PubMed ID: 7746029
[TBL] [Abstract][Full Text] [Related]
37. A randomized placebo-controlled polysomnographic study of eszopiclone in Japanese patients with primary insomnia.
Uchimura N; Kamijo A; Kuwahara H; Uchiyama M; Shimizu T; Chiba S; Inoue Y
Sleep Med; 2012 Dec; 13(10):1247-53. PubMed ID: 23063301
[TBL] [Abstract][Full Text] [Related]
38. Effects of triazolam on sleep, daytime sleepiness, and morning stiffness in patients with rheumatoid arthritis.
Walsh JK; Muehlbach MJ; Lauter SA; Hilliker NA; Schweitzer PK
J Rheumatol; 1996 Feb; 23(2):245-52. PubMed ID: 8882027
[TBL] [Abstract][Full Text] [Related]
39. The effect of zolpidem in patients with fibromyalgia: a dose ranging, double blind, placebo controlled, modified crossover study.
Moldofsky H; Lue FA; Mously C; Roth-Schechter B; Reynolds WJ
J Rheumatol; 1996 Mar; 23(3):529-33. PubMed ID: 8832997
[TBL] [Abstract][Full Text] [Related]
40. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults.
Roth T; White D; Schmidt-Nowara W; Wesnes KA; Niebler G; Arora S; Black J
Clin Ther; 2006 May; 28(5):689-706. PubMed ID: 16861091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
